USP4 is regulated by Akt phosphorylation and deubiquitylates TGF-β type I receptor
Long Zhang,*P , which has been associated with poor prognosis in breast cancer 5, 6 , associates with and phosphorylates USP4. Akt mediated phosphorylation relocates USP4 to cytoplasm and membrane and is required for maintaining its protein stability. Moreover, Akt-induced breast cancer cell migration was inhibited by USP4 depletion and TβRI kinase inhibition. Our results identified USP4 as an important determinant for crosstalk between TGF-β and Akt, which provides new opportunities for cancer treatment.
TGF-β is of critical importance for embryogenesis and tissue homeostasis of multicellular organisms. Perturbations in its signaling pathways have been linked to a diverse set of human diseases, including cancer 7, 8 . The TGF-β activated serine/threonine kinase receptor complex propagates the signal by phosphorylating receptor regulated (R)-Smads, i.e Smad2 and Smad3. Activated R-Smads form hetero-oligomers with Smad4 that accumulate into the nucleus to regulate a large number of target genes 1, 2, 7, 8 . Besides
Smad pathway, also non-Smad signaling pathways are initiated that include the phosphatidylinositol-3-kinase (PI3K)/AKT pathway [9] [10] [11] . These non-canonical pathways are also activated by growth factors that signal via tyrosine kinase receptors to mediate cell proliferation, survival and migration. During cancer progression, TGF-β frequently switches from tumor suppressor to tumor promoter. Oncogenic signals may blunt TGF-β-induced growth arrest and apoptosis, while enhance TGF-β-induced pro-invasive and pro-metastatic responses, and this may involve a change in balance between canonical and non-Smad signaling [12] [13] [14] TGF-β signaling is intricately controlled by multiple positive and negative regulators. Smad7 is a potent negative regulator of TGF-β signaling by recruiting Smurf E3 ubiquitin ligases to the activated TβRI and targeting this receptor for degradation 15, 16 .
Whether this process can be reversed via action of specific deubiquitinating enzymes (DUBs) [17] [18] [19] [20] is unknown. To identify novel critical components of TGF-β signaling, we performed a gain of function screen overexpressing 27,000 genes using a TGF-β-induced Smad3/4 driven transcriptional reporter as read out. Multiple DUBs, including USP4, -was just known as a deubiquitinating enzyme for R-Smad 21 . An independent screen with 69 Flag-tagged DUB cDNAs (with comparable expression levels of each DUB) confirmed the same USPs as selective activators of TGF-β, but not IL1β/NFκ-induced transcriptional response ( Supplementary Fig. S1a and S1b and data not shown). In contrast to USP4 wild-type, the USP4 CS mutant (carrying a point mutation in one of the key cysteines of the catalytic domain) did not potentiate TGF-β signaling (Fig.1b) . This suggests that the DUB activity is needed for this response. Knock-down with two independent shRNAs that selectively target USP4, demonstrated that endogenous USP4 expression is required for maximal TGF-β-induced transcriptional response in HEK293T cells (Fig. 1c) . These results were consolidated in other cell types. Ectopic expression of wild-type USP4, but not the CS mutant increased both magnitude and duration of TGF-β-induced Smad2/Smad4 complex formation in MCF10A-Ras (M2) breast cancer cells (Fig. 1d) . Depletion of endogenous USP4 decreased this effect in MDA-MB-231 breast cancer cells (Fig.1e) . Moreover, both duration and intensity of TGF-β-induced Smad2 phosphorylation and downstream target gene expression were impaired in USP -/-cells compared to USP +/+ mouse embryonic fibroblasts (MEFs) (Fig. 1f and 1g) . To investigate the role of USP4 in vivo we depleted USP4 in zebrafish using morpholino oligonucleotides (with depleting effects confirmed, data not shown), and observed a serious epiboly defect before the formation of zebrafish tail bud is completed (data not show). Usp4 morphant embryos showed severe inhibition in expression of TGF-β targets goosecoid (gsc) and notail (ntl) (Fig. 1h) , and these genes were elevated in embryos injected with usp4 mRNA as measured by in situ hybridization (Fig. 1h) . Consistently, qPCR results of gsc, ntl, sox17 and sox32 confirmed the effects of USP4 expression on target gene expression in vivo (Fig. 1i) , Taken together, these results indicate that USP4 is a critical regulator of TGF-β signaling in mammalian cells and zebrafish embryos.
The results above indicate that USP4 acts as a deubiquitylase in the TGF-β pathway, and operates upstream of R-Smad activation. This prompted us to test whether USP4 targets TGF-β receptor function. We first analyzed whether USP4 and TβRІ can physically interact with each other. Upon overexpression, USP4 binds TβRІ (Supplementary Fig S2a) . Interestingly, the association with (endogenous) USP4 was more efficient upon TβRI activation ( Supplementary Fig S2a and S2b) . Moreover, USP4
antibodies were able to co-immunoprecipate 125 I-TGF-β affinity labeled endogenous receptors, which validates the interaction between USP4 and TGF-β receptor (Fig. 2a) .
Furthermore, endogenous USP4 was found to interact with TβRI in a TGF-β-induced manner in HeLa cells (Fig. 2b) . Therefore, USP4 binds TβRІ at physiological conditions. We eluted TβRІ from a USP4 complex. We found wild-type USP4 associated TβRІ was not ubiquitinated while USP4 cs mutant associated TβRІ was highly ubiquitinated (Fig. S2c) . We thus asked if USP4 serves as a DUB for TβRІ. Firstly, Flagtagged caTβRІ proteins were affinity purified and their ubiquitination pattern was visualized by immunoblotting for HA-ubiquitin; polyubiquitination appeared as a major modification of TβRІ. Overexpression of wild-type USP4, but not of a catalytically inactive USP4 mutant, inhibited TβRІ Lysine 48 polyubiquitination in the absence or presence of proteasome inhibitor MG132 (Fig. 1c) . TGF-β receptor signaling induces Smad7 expression, which subsequently targets TβRІ degradation by recruiting E3 ligase Smurf2 15, 16 . USP4 opposed Smad7/Smurf2-induced TβRІ ubiquitination ( Supplementary Fig. 2d ), and blocked TGF-β-induced TβRІ ubiquitination at the endogenous level (Fig. 2d) . Conversely, USP4 depletion enhanced TGF-β-induced TβRІ Lysine 48 polyubiquitination (Fig.2e) . The modification of TβRІ by Lysine-48 linked polyubiquitination has been reported to promote its internalization and degradation 22 . We therefore tested whether USP4 misexpression can regulate TβRІ levels at the plasmembrane, the location where signaling is initiated 22 . When coexpressed with wildtype USP4, but not with the catalytically inactive mutant, biotin-labeled cell surface TβRI receptor displayed a prolonged half-life (Fig. 2f ). In line with this finding, USP4 depletion in MDA-MB-231 cells led to lower cell surface TβRІ expression and accelerated degradation (Fig 2g) . Moreover, when compared to USP4
MEFs showed lower expression level and shorter half-life of TβRI (Fig.2h) . These findings indicate that USP4 is a DUB for TβRI and contributes to increased stability of TβRI at the plasmamembrane. USP4 is highly expressed in different cancers, including breast cancer 23 . TGF-β stimulates epithelial to mesenchymal transition (EMT), cell migration, invasion and metastasis of breast cancer 7, 24 . Typical EMT changes are: upregulation of N-cadherin, fibronectin, smooth muscle actin and vimentin and downregulation of E-cadherin 25 .
Upon depletion of USP4, TGF-β-induced changes in EMT marker expression were attenuated (Fig. 3a) . Conversely, ectopic expression of USP4, but not its CS inactive mutant, potentiated these TGF-β-induced changes in expression (Fig.3b) . Consistent with these results, USP4 knockdown attenuated TGF-β-induced migration of MDA-MB-231 cells (Fig. 3c) . These results suggest that USP4 regulates TGF-β-induced EMT and migration of breast cancer cells in vitro.
We next examined the effect of USP4 misexpression in breast cancer cells in vivo by using zebrafish embryo xenograft model where mammalian tumor cells are injected into the zebrafish embryonic blood circulation (for technical details, see materials and methods) (Fig. 3d) . MCF10A-Ras cells stably infected with wild-type USP4, inactive USP4 CS mutant or an empty vector control were injected into the blood circulation of the zebrafish embryo. Invasion and micrometastasis were measured using fluorescent microscopy every second day in the avascular tail fin area of the embryo. Confocal microscopy was used to visualize the invading tumor cells (labeled in red), against the Fli:GFP background of the zebrafish embryo which labels blood vasculature (green).
Individual cell invasion can be detected in this model (He et al submitted). Over 5 days, a marked increase of invasion was visible upon ectopic expression of wild type USP4, but not its inactive CS mutant (Fig. 3e, f) . Treatment with SB431542, a selective TβRІ kinase inhibitor, reduced the invasion and micrometastasis of all samples ( Fig.3f and 3g ).
At the end of the 5 days, wild-type USP4 infection in MCF10A-Ras cells resulted in 55% of zebrafish embryos displaying invasion, whilst the USP4 cs mutant and control samples showed invasion in 35% and 36% embryos, respectively (p<0.01) ( Fig. 3f and 3g ). Due to the transparent nature of the zebrafish embryo, invading cells were also visible with light microscopy (Fig.3h ).
MDA-MB-231 is a highly aggressive human breast cancer cell line, and metastasis of these cells in a mouse and zebrafish embryo xenograft model were found to be dependent on TGF-β receptor signaling in tumor cells 26, 27 (Drabsch and ten Dijke, unpublished results) . In vitro qPCR analysis indicated that endogenous USP4 is required for efficient induction of metastasis-related TGF-β target genes, such as IL-11, CTGF, CXCR4, PTHrP and MMPs (Fig. 3i) . Similar results were obtained with other shUSP4 lentivirus (data not shown).
Subsequently, invasion and metastasis properties of USP4 depleted MDA-MB-231 cells were analyzed in zebrafish embryos. MDA-MB-231 cells with stable depletion of endogenous USP4 were injected into the ducts of Cuvier 48 hpf. The zebrafish embryos were analyzed over 5 dpi (see representative images of the tail fin area in Fig.   3j ). The control cells showed 62% of zebrafish embryos with invasion, whereas knockdown of USP4 by 3 independent shRNAs attenuated the invasion (Fig. 3k) .
Furthermore, the amount of micrometastasis was also reduced upon USP4 depletion (Fig.3l ). Taken together, these results suggest that USP4 stimulates TGF-β-induced breast cancer invasion and metastasis.
When we analyzed the subcellular distribution of endogenous USP4, we found it to be mainly present in nucleus. This prompted us to investigate how USP4 could maintain cell surface TβRІ levels at the plasmamembrane. Sequence analysis revealed that USP4 contains an Akt consensus RxRxxS/T phosphorylation motif 6 at Ser 445. The motif is also conserved in USP4 orthologues (Fig 4a) . It has been shown that for certain Akt substrates, phosphorylation triggers their nuclear export 28 . We therefore reasoned that USP4 is a substrate of Akt, whose phosphorylation may influence USP4 subcellular localization. Consistent with the hypothesis, we found that an activated allele of Akt (myr-Akt1) interacts with USP4 in transfected cells (Fig. 4b ). In addition, USP4 was found to associate with Akt endogenously (Fig. 4c) . To examine whether USP4 is a substrate for Akt, we used a phospho-specific antibody that recognizes the optimal Akt consensus phosphorylation motif (p-Ark substrate). We found that expression of activated Akt significantly enhanced the phosphorylation of wild-type USP4, whereas USP4-S445A phosphorylation was not detected by p-Artk substrate antibody ( Fig. 4b and   4d ). The reactivity of USP4 with this antibody was reversed when the cell lysates were incubated with lambda phosphatase (Fig. 4e) . Moreover, insulin growth factor (IGF)-1 or TGF-β-induced endogenous USP4 phosphorylation as detected by the Akt substrate antibody. Notably, the phosphorylation of USP4 was decreased in cells that were treated with LY294002, a selective inhibitor for phosphatidylinositol 3-kinase (PI3K) (Fig. 4f) .
To investigate the effect of Akt on USP4 subcelluar localization we used HeLa cells stably expressing wild type USP4 or USP4 S44A/S445D mutants and confocal analysis. While USP4 S445A mutant was almost exclusively present in the nuclei, the USP4 S445D showed a significant increase in cytoplasmic localization when compared with wild-type USP4 (Fig. 4g) . Importantly, LY294002 treatment reduced the cytoplasmic signal of endogenous USP4 (Fig. 4h) . To validate these findings, we examined the effect of activated myr-Akt on the localization of wild type USP4 or S44A/S44D USP4 mutants using immunofluorescence microscopy and cellular fractionation. We observed that the expression of activated myr-Akt promoted the cytoplasmic and membrane localization of wild-type USP4 (Fig 4i and 4j) . In contrast, in the presence of activated Akt the non-phosphorylatable S445A USP4 mutant was still restricted to the nuclear compartment (Fig 4i and 4j) . Conversely, a significant fraction of the phospho-mimetic USP4 S445D mutant was located in the cytoplasm, and its localization was not much affected by the expression of activated Akt (Fig 4i and data not shown). Futhermore, endogenous USP4 located in membrane and cytoplasm became completely nuclear or increased in membrane/cytoplasm localization upon LY294002 treatment and activated Akt expression, respectively (Fig. 4k) . These results together indicate that Akt-induced USP4 phosphorylation affects its subcelluar distribution by promoting more USP4 to be present in membrane and cyoplasm.
USP4 is a stable protein as it can deubiquitylate itself 29 ; Consistent with this, wild type USP4 was found to be more stable than USP4 CS mutant (data not shown).
Time-course experiments in cells subjected to treatment with protein synthesis inhibitor cycloheximide (CHX) in the absence or presence of LY294002 or ectopically expressed activated Akt revealed that USP4 halflife was shortened and prolonged, respectively (Fig   5a) . Consistent with these results we found that the S445A mutant was degraded more rapidly than wild-type USP4 and S445D mutant (Fig. 5b) . Compared with wild-type USP4, S445A mutant demonstrated an increased level of conjugation with polyubiquitin chains (Fig. 5c) , suggesting that the impaired protein halflife of the S445A mutant is due to its elevated ubiquitination. We found that USP4 formed complex with itself and also interacted with USP15, USP19 and USP11, the other DUBs that were identified in our genetic screen (Fig. S3a) . Mutation of the Akt phosphorylation site on USP4 (S445A mutant) mitigated the ability to associate with itself or other USPs ( Fig. 5d and 5e , Supplementary Fig. S3b ). Particularly, when USP4 was coexpressed with USP15, we observed an elevation in USP4 expression ( Supplementary Fig. S3a ). An enforced long stability of USP4 protein was detected when it was co-expressed with USP15 (Fig. 5f ).
These data suggest that Akt mediated phosphorylation on Ser 445 is required for USP4 to form homomeric complexes and heteromeric complexes with other DUBs, particularly with USP15. As USP4 binding partners, USP15, USP19 and USP11 were also observed to deubiquitinate TβRІ when they were overexpressed (Fig.S3c) . We focused on USP15 and found it could also serve as a deubiquitylase for TβRІ ( Supplementary Fig. S3d ) but that this relied on endogenous USP4 (Supplementary Fig. S3e ).
Consistent with the notion that wild-type USP4 and USP4 S445D mutant are more located at plasmamembran and stable than USP4 S445A mutant, we found that S445A mutant had lost the ability to remove polyubiquitin chains from TβRІ (Fig. 5g ).
This suggests that Akt mediated USP4 phosphorylation is required for USP4 to serve as a deubiquitylase for TβRІ. To further investigate the functional cooperation between PI3K/Akt and TGF-β/TβRI signaling pathways via USP4, we examined the effect of USP4 depletion or TβRІ kinase inhibitor on IGF-1-or activated myr-Akt-induced migration of MDA-MB -231 cells. We found that both treatments could partially reduce IGF-1/Myr-Akt-induced cell migration ( Fig. 5h and 5i) . Our current study suggest a working model in which in invasive/metastatic breast cancer cells, Akt activated by growth factors/TGF-β induces phosphorylation of USP4, which associates with TβRI in the membrane to stabilize it, and then enforces the TGF-β receptor-induced promigratory/invasive and metastatic responses in breast cancer cells (Fig. 5j) . Akt has been shown to reduce Smad3 function in Hep3B cells in which TGF-β induces an apoptotic response 30, 31 . Akt can directly associate with unphosphorylated Smad3 and sequester it outside the nucleus. However, Smad3 levels are often reduced in advanced human tumors with low levels being sufficient for tumor promotion 32, 33 . Activation of Akt may redirect TGF-β signaling and thereby contribute to its switch from tumor suppressor to tumor promoter. With DUBs being druggable targets 34 , it would be interesting to develop inhibitors for USP4 and test their potential for anti-invasive and anti-metastatic properties. Nickel pull down assay. Cells were lysed in 6M guanidine-HCl, 0.1 M Na 2 HPO 4 /NaH 2 PO 4 , and 10 mM imidazole, followed by nickel bead purification and immunoblot analysis.
METHODS

Real-time RT-PCR (qRT-PCR).
Total RNAs were prepared using NucleoSpin® RNA II kit (BIOKÉ, Netherlands). 1 μg RNA was reverse-transcribed using the RevertAid Zebrafish embryo assay. Zebrafish (Danio rerio), AB strain, were kept at 28.5°C under a light and dark cycle of 14 and 10 hours, respectively. Fish staging and embryo production were carried out as described previously 36, 37 . Capped mRNAs were synthesized using T7 Cap Scribe (Roche) according to the manufacturer's instructions.
For preparation of digoxigenin labeled antisense probe, plasmid containing the usp4 cDNAs was linearized with KpnI. Linearized template DNA was transcribed in vitro with T7 polymerase using the digoxigenin-UTP (Roche). In situ hybridizations were performed as previously described (Fig. 3d) . After injection, some of the tumour cells disseminate into the embryo blood circulation whilst the rest remain in the yolk. Zebrafish embryos are maintained for 5 days post injection (dpi) at 33˚C, a compromise for both the fish and cell lines 40 . The tumor cells that enter into the blood stream preferentially invade and micrometastasise into the posterior tail fin area (Fig.   3e ). Invasion is can be visualized as a single cell which has left the blood vessel which can subsequently form a micrometastasis (3~50 cells). Pictures were taken by confocal microscopy at 1, 3 and 5 dpi and the percentage of invasion and micrometastasis were counted. Every experiment was repeated at least two times independently. Cellular fractions. Cytosolic, membrane and nuclear fractions were prepared using the ProteoExtract kit (Calbiochem) according to the manufacturer's instructions.
Statistical analysis.
Statistical analyses were performed with a two-tailed unpaired t-test. P < 0.05 was considered statistically significant.
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